2019
Adjuvant Hormonal Therapy for Low-Grade Endometrial Stromal Sarcoma
Deshmukh U, Black J, Perez-Irizarry J, Passarelli R, Levy K, Rostkowski A, Hui P, Rutherford TJ, Santin AD, Azodi M, Silasi DA, Ratner E, Litkouhi B, Schwartz PE. Adjuvant Hormonal Therapy for Low-Grade Endometrial Stromal Sarcoma. Reproductive Sciences 2019, 26: 600-608. PMID: 29843577, DOI: 10.1177/1933719118778801.Peer-Reviewed Original ResearchConceptsLow-grade endometrial stromal sarcomaRecurrence-free survivalStage I patientsEndometrial stromal sarcomaAromatase inhibitorsI patientsStage IIStromal sarcomaAdvanced low-grade endometrial stromal sarcomaMean recurrence-free survivalLonger recurrence-free survivalAdjuvant hormonal therapyMedian followProgestin groupUnderwent hysterectomyHormonal therapyDisease recurrenceSide effectsPatientsStage IProgestinsMonthsSarcomaDiseaseTreatment
2016
Sarcomas and Related Mesenchymal Tumors
Tallini G, de Biase D, Hui P. Sarcomas and Related Mesenchymal Tumors. 2016, 487-506. DOI: 10.1007/978-3-319-19674-9_37.Peer-Reviewed Original ResearchManagement of patientsMesenchymal tumorsClinical managementMesenchymal lesionsPathological diagnosisTumor subsetsRecurrent chromosomal changesClinical practiceSarcomaTumor phenotypeMolecular pathologyRelative rarityNext-generation sequencingTumorsChromosomal changesDiagnosisNovel technical approachCytogenetics
2011
Gestational Choriocarcinoma
Hui P. Gestational Choriocarcinoma. Current Clinical Pathology 2011, 127-137. DOI: 10.1007/978-1-61779-394-3_8.Peer-Reviewed Original ResearchGestational choriocarcinomaMalignant tumorsMethotrexate-based chemotherapyMortality of patientsDecidua of pregnancyHematogenous spreadCure rateFatal malignancyTrophoblastic diseaseChemotherapy managementAggressive formChoriocarcinomaChorial villiTumorsTumor cellsSarcomaDiseaseChemotherapyPatientsPregnancyDramatic decreaseMalignancyMortalityPlacentaDecidua
2005
HMGA proteins in malignant peripheral nerve sheath tumor and synovial sarcoma: preferential expression of HMGA2 in malignant peripheral nerve sheath tumor
Hui P, Li N, Johnson C, De Wever I, Sciot R, Manfioletti G, Tallini G. HMGA proteins in malignant peripheral nerve sheath tumor and synovial sarcoma: preferential expression of HMGA2 in malignant peripheral nerve sheath tumor. Modern Pathology 2005, 18: 1519-1526. PMID: 16056249, DOI: 10.1038/modpathol.3800464.Peer-Reviewed Original ResearchConceptsMalignant peripheral nerve sheath tumorPeripheral nerve sheath tumorsNerve sheath tumorsSheath tumorsSynovial sarcomaSYT-SSX fusion transcriptsRoutine surgical pathology practiceStaining patternMonophasic synovial sarcomaReal-time reverse transcription-polymerase chain reactionAvailable immunohistochemical markersReverse transcription-polymerase chain reactionSurgical pathology practiceTranscription-polymerase chain reactionExpression of HMGA2Nuclear staining patternHistological diagnosisPolymerase chain reactionProtein immunohistochemistryBiphasic tumorSignificant immunoreactivityImmunohistochemical markersImmunohistochemical stainingSarcomaGlandular component
2004
Human herpesvirus‐8 is not associated with angiolymphoid hyperplasia with eosinophilia
Bhattacharjee P, Hui P, McNiff J. Human herpesvirus‐8 is not associated with angiolymphoid hyperplasia with eosinophilia. Journal Of Cutaneous Pathology 2004, 31: 612-615. PMID: 15330993, DOI: 10.1111/j.0303-6987.2004.00240.x.Peer-Reviewed Original ResearchConceptsHHV-8 DNAHHV-8Immunohistochemical studyHuman herpesvirus 8 DNACases of ALHEMultiple red papulesHuman herpesvirus 8Majority of casesPolymerase chain reaction analysisAngiolymphoid hyperplasiaRed papulesKaposi's sarcomaALHEHerpesvirus 8Chain reaction analysisAngioproliferative lesionsNeck regionRemaining tissueEosinophiliaSarcomaHyperplasiaContradictory dataAssociationReaction analysisPCR analysis